Back to search
FDAFDA · Food and drugs·Recall number D-0386-2021

Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, 30-count bottle, Rx only, Mfd. By:KVK-Tech, Inc., Newtown, PA, 18940 NDC 10702-055-03

Published May 26, 2021 · Recall initiated: April 27, 2021

Summary

FDA records drug Class III recall D-0386-2021, published May 26, 2021 and initiated April 27, 2021. Recalling firm: KVK-Tech, Inc.; Status: Terminated; Reported quantity: 17,096 bottles; Lot: Lot: 15684A, Exp 7/2021. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Impurities/Degradation Specifications

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
Manufacturer
KVK-Tech, Inc.
Distributor
Distributed Nationwide in the USA
Lot
Lot: 15684A, Exp 7/2021
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, 30-count bottle, Rx only, Mfd. By:KVK-Tech, Inc., Newtown, PA, 18940 NDC 10702-055-03 recalled?

Yes. FDA published recall D-0386-2021 on May 26, 2021. Reported hazard: Failed Impurities/Degradation Specifications

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE.